173 related articles for article (PubMed ID: 9219559)
1. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors.
Germolec DR; Spalding J; Boorman GA; Wilmer JL; Yoshida T; Simeonova PP; Bruccoleri A; Kayama F; Gaido K; Tennant R; Burleson F; Dong W; Lang RW; Luster MI
Mutat Res; 1997 Jun; 386(3):209-18. PubMed ID: 9219559
[TBL] [Abstract][Full Text] [Related]
2. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors.
Germolec DR; Spalding J; Yu HS; Chen GS; Simeonova PP; Humble MC; Bruccoleri A; Boorman GA; Foley JF; Yoshida T; Luster MI
Am J Pathol; 1998 Dec; 153(6):1775-85. PubMed ID: 9846968
[TBL] [Abstract][Full Text] [Related]
3. Arsenic induces overexpression of growth factors in human keratinocytes.
Germolec DR; Yoshida T; Gaido K; Wilmer JL; Simeonova PP; Kayama F; Burleson F; Dong W; Lange RW; Luster MI
Toxicol Appl Pharmacol; 1996 Nov; 141(1):308-18. PubMed ID: 8917704
[TBL] [Abstract][Full Text] [Related]
4. Role of keratinocyte-derived cytokines in chemical toxicity.
Luster MI; Wilmer JL; Germolec DR; Spalding J; Yoshida T; Gaido K; Simeonova PP; Burleson FG; Bruccoleri A
Toxicol Lett; 1995 Dec; 82-83():471-6. PubMed ID: 8597097
[TBL] [Abstract][Full Text] [Related]
5. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
6. An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.
Scott KA; Moore RJ; Arnott CH; East N; Thompson RG; Scallon BJ; Shealy DJ; Balkwill FR
Mol Cancer Ther; 2003 May; 2(5):445-51. PubMed ID: 12748306
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is expressed in mouse skin in response to tumor-promoting agents and modulates dermal inflammation and epidermal dark cell numbers.
Vasunia KB; Miller ML; Puga A; Baxter CS
Carcinogenesis; 1994 Apr; 15(4):653-60. PubMed ID: 8149476
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: Stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization.
Mann A; Breuhahn K; Schirmacher P; Blessing M
J Invest Dermatol; 2001 Dec; 117(6):1382-90. PubMed ID: 11886498
[TBL] [Abstract][Full Text] [Related]
9. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin.
Wilmer JL; Burleson FG; Kayama F; Kanno J; Luster MI
J Invest Dermatol; 1994 Jun; 102(6):915-22. PubMed ID: 8006454
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony stimulating factor gene expression and function during tumor promotion.
Robertson FM; Bijur GN; Oberyszyn AS; Pellegrini AE; Boros LG; Sabourin CL; Oberyszyn TM
Carcinogenesis; 1994 May; 15(5):1017-29. PubMed ID: 8200063
[TBL] [Abstract][Full Text] [Related]
12. Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice.
Xie Y; Trouba KJ; Liu J; Waalkes MP; Germolec DR
Environ Health Perspect; 2004 Aug; 112(12):1255-63. PubMed ID: 15345372
[TBL] [Abstract][Full Text] [Related]
13. Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.
Mustacich D; Wagner A; Williams R; Bair W; Barbercheck L; Stratton SP; Bhattacharyya AK; Powis G
Carcinogenesis; 2004 Oct; 25(10):1983-9. PubMed ID: 15166090
[TBL] [Abstract][Full Text] [Related]
14. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
[TBL] [Abstract][Full Text] [Related]
15. Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes.
Dlugosz AA; Cheng C; Denning MF; Dempsey PJ; Coffey RJ; Yuspa SH
Cell Growth Differ; 1994 Dec; 5(12):1283-92. PubMed ID: 7535082
[TBL] [Abstract][Full Text] [Related]
16. Up- and down-regulation of granulocyte/macrophage-colony stimulating factor activity in murine skin increase susceptibility to skin carcinogenesis by independent mechanisms.
Mann A; Breuhahn K; Schirmacher P; Wilhelmi A; Beyer C; Rosenau A; Ozbek S; Rose-John S; Blessing M
Cancer Res; 2001 Mar; 61(5):2311-9. PubMed ID: 11280804
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse.
Battalora MS; Spalding JW; Szczesniak CJ; Cape JE; Morris RJ; Trempus CS; Bortner CD; Lee BM; Tennant RW
Carcinogenesis; 2001 Apr; 22(4):651-9. PubMed ID: 11285202
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.
Budunova IV; Kowalczyk D; Pérez P; Yao YJ; Jorcano JL; Slaga TJ
Oncogene; 2003 May; 22(21):3279-87. PubMed ID: 12761498
[TBL] [Abstract][Full Text] [Related]
19. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene.
Spalding JW; Momma J; Elwell MR; Tennant RW
Carcinogenesis; 1993 Jul; 14(7):1335-41. PubMed ID: 8330346
[TBL] [Abstract][Full Text] [Related]
20. TGF alpha is dispensable for skin tumorigenesis in Tg.AC mice.
Humble MC; Szczesniak CJ; Luetteke NC; Spalding JW; Cannon RE; Hansen LA; Lee DC; Tennant RW
Toxicol Pathol; 1998; 26(4):562-9. PubMed ID: 9715516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
